Status:
UNKNOWN
Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation
Lead Sponsor:
Dr Andrew Stevens
Collaborating Sponsors:
Probe Scientific Limited
Conditions:
Traumatic Brain Injury
Acquired Brain Injury
Eligibility:
All Genders
16+ years
Brief Summary
This study evaluates the validity of an intravascular continuous glucose monitoring microdialysis probe, and compares the values to routinely inserted cerebral glucose microdialysis to evaluate the hy...
Detailed Description
All recruited patients will in any case have probes inserted in theatre for brain tissue glucose monitoring as a part of their standard clinical care. Probes will be allowed to stabilize following ins...
Eligibility Criteria
Inclusion
- Aged 16 and over
- New episode of acquired brain injury, of any form to include haemorrhage, trauma, infarction
- Their condition necessitates admission to and care on neurocritical care
- Their condition necessitates intracerebral microdialysis probe insertion
- Their condition necessitates arterial line insertion/central venous access and regular/venous blood gas sampling.
Exclusion
- Refusal or withdrawal of consultee agreement and any known patient wishes precluding inclusion.
- Pregnancy.
- Peripheral venous cannulation clinically contraindicated.
- Patients already enrolled in three or more other research studies.
Key Trial Info
Start Date :
January 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03246607
Start Date
January 26 2020
End Date
October 1 2020
Last Update
July 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ